|
Corporate Social Responsibility
News
2.20.2007 - 01:00pm ET
|
CSR News from:
|
Investor Environmental Health Network
|
|
News Categories: |
| | |
REPORT: What Price Beauty? Risk Posed by Toxics in Cosmetics Could Leave Unwary Investors with a Black Eye
Growing Regulatory, Consumer Pressure Pose Major Challenges for Cosmetics Industry, Retailers; Bed, Bath & Beyond and CVS Face Related 2007 Proxy Votes
(CSRwire) WASHINGTON, D.C. – February 20, 2007 — Things could get ugly for
investors who ignore glaring health risks in the cosmetics industry, warns
a new report from the Investor Environmental Health Network (IEHN), which
represents 20 investment organizations with $22 billion in assets under
management. A powerful convergence of forces – including shareholder
resolutions, improved health risk information, European and U.S.
regulatory changes and growing consumer pressure -- could drive sweeping
changes in the U.S. personal care and cosmetics industry, with significant
implications for investors, according to IEHN.
The release of the IEHN report caps a flurry of developments in recent
weeks exposing the risks associated with toxic-bearing cosmetics and the
retailers who provide them to the public. Investors are now weighing two
related shareholder resolutions at CVS (which holds its annual meeting on
or about May 12th) and Bed, Bath & Beyond (where shareholders meet on or
about June 29th). On February 8, 2007, Innovest Strategic Value Advisors,
a financial research firm, released a report that the risk of “toxic
lockouts” could result in a loss of market share and loss of market
access for four major industries, including cosmetics. On January 25,
2007, it was announced that 500 cosmetics companies – including The Body
Shop and Burt’s Bees – had signed the Compact for Safe Cosmetics, a
pledge to eliminate toxic ingredients from their products nationwide.
Entitled “Beneath the Skin: Hidden Liabilities, Market Risk and Drivers
of Change in the Cosmetics and Personal Care Products Industry,” the new
IEHN report describes a ticking time bomb scenario of a largely
self-policed industry in which regulatory action by the U.S. Food and Drug
Administration (FDA) typically is triggered only by reporting from the
companies themselves. "The result is a system that permits significant
consumer exposure to occur before sufficiently rigorous safety testing is
conducted — ultimately, a game of roulette which places consumers,
manufacturers and investors at risk," said Sanford Lewis, an attorney
specializing in corporate accountability and one of the report's
authors.
The U.S. cosmetics industry, which is dominated by 10 large companies,
accounts for the use of nearly one in seven of the 75,000 chemicals
registered for use in the United States. However, the FDA bans or
restricts only nine of those substances, the report states.
Common ingredients found in U.S. personal-care products include
phthalates, which have been linked to malformed or underdeveloped
reproductive organs in males; formaldehyde, classified as a carcinogen;
and parabens, endocrine-active preservatives that have been found in
breast tumors. Many ingredients are exempt from labeling requirements
because the product formulas are protected as proprietary, the report
notes.
Scientists and consumers also have expressed concern that the industry's
use of nanoparticles — which involve the manipulation of microscopic
particles — may allow them to penetrate into the bloodstream and the
lymph system and damage tissue.
“Once they surface, health hazards may pose a serious threat to brand
loyalty with significant implications for profitability and market share.
It is difficult to overstate the potential magnitude of this challenge,"
said Lauren Compere, director of shareholder advocacy at Boston Common
Asset Management, which has introduced shareholder resolutions on safer
cosmetics at CVS Corporation.
The weak U.S. regulatory structure also limits product marketability in
the 457-million person European market. In 2005, the European Union
banned more than 1,000 chemicals for use in cosmetics, the report notes.
Closer to home, both California, the world's sixth-largest economy, and
Canada have tightened their regulations of personal-care products.
A total of 500 manufacturers, distributors and retailers have signed the
Compact for Safe Cosmetics, a pledge to phase out hazardous materials in
cosmetics and personal-care products within three years, and to meet the
tough new European standards worldwide, the report notes. Unfortunately,
many of the industry’s largest companies, including Avon, Estée Lauder,
and Procter & Gamble, have refused to take the same common-sense step.
Instead, the cosmetics industry has begun touting its Consumer Commitment
Code, which appears to do little more than defend the status quo: the
industry’s self-policed ingredient review process and the inadequate
“remedy” of voluntary reporting to the FDA.
The code “appears to do little if anything to encourage cosmetics
companies to eliminate the array of substances of concern for long-term
health issues such as reproductive, cancer and endocrine impacts that are
being flagged in the scientific literature,” the IEHN report notes.
"Companies that proactively reformulate their products based upon emerging
concerns about chemical safety will enhance their competitive positioning
and position themselves to avoid future regulatory costs," said Karen
Shapiro, shareholder advocacy associate at Domini Social Investments LLC,
which has introduced resolutions in the past at Avon Products. "They may
also maintain a competitive edge in global markets.”
The authors of “Beneath the Skin” recommend that investors in
cosmetics industry companies: compare and benchmark cosmetics and
personal care companies on their performance on these issues; demand
greater disclosure; monitor emerging scientific data; and anticipate
tighter regulation and changing markets.
“A cosmetics company that explores less toxic reformulations, embraces a
greater degree of pre-market testing for health impacts, and expands its
positioning in the use of natural ingredients stands to gain,” the IEHN
report concludes.
ABOUT IEHN
The Investor Environmental Health Network (www.iehn.org) is a collaboration of
investment managers encouraging companies to adopt "safer chemicals"
policies for cosmetics and other products. Members of the network are
concerned that companies will be locked out of markets and suffer
financial and reputational damage, if they don't systematically identify
and eliminate hazardous chemicals in their products.
Report available for download at http://iehn.org
|
|